Average Insider

Where insiders trade, we follow

Insider Buy/Sell Ratio — Last 7 Days

Extreme outlier transactions (>3σ) are excluded.Show All Data
Ratio0.1:1
Daily Buy & Sell Volume

By Sector

By Industry

Jun 30, 2026
Sale
Shares
41,278
Price
$97.77
Total Value
$4.04M
Shares Held After
47,732
% of Holdings
46.4%
Jun 30, 2026
Sale
Shares
12,697
Price
$96.84
Total Value
$1.23M
Shares Held After
89,010
% of Holdings
12.5%
Jun 30, 2026
Sale
Shares
2,527
Price
$95.54
Total Value
$241.44K
Shares Held After
101,707
% of Holdings
2.4%
Jun 30, 2026
Sale
Shares
3,458
Price
$94.66
Total Value
$327.32K
Shares Held After
104,234
% of Holdings
3.2%
Jun 30, 2026
Sale
Shares
46,744
Price
$99.54
Total Value
$4.65M
Shares Held After
3,138,612
% of Holdings
1.5%
Jun 30, 2026
Sale
Shares
41,901
Price
$98.69
Total Value
$4.14M
Shares Held After
3,185,356
% of Holdings
1.3%
Jun 30, 2026
Sale
Shares
76,659
Price
$97.77
Total Value
$7.50M
Shares Held After
3,227,257
% of Holdings
2.3%
Jun 30, 2026
Sale
Shares
23,581
Price
$96.84
Total Value
$2.28M
Shares Held After
3,303,916
% of Holdings
0.7%
Jun 30, 2026
Sale
Shares
4,692
Price
$95.54
Total Value
$448.29K
Shares Held After
3,327,497
% of Holdings
0.1%
Jun 30, 2026
Sale
Shares
6,423
Price
$94.66
Total Value
$607.98K
Shares Held After
3,332,189
% of Holdings
0.2%
Jun 30, 2026
Sale
Shares
78,560
Price
$95.69
Total Value
$7.52M
Shares Held After
3,338,612
% of Holdings
2.3%

CoreWeave, Inc. (CRWV)

Jain Sachin — Chief Operating Officer
Jun 30, 2026
Sale
Shares
3
Price
$95.69
Total Value
$287.07
Shares Held After
127,633
% of Holdings
0.0%

Beam Therapeutics Inc. (BEAM)

Simon Amy — Chief Medical Officer
Jun 30, 2026
Sale
Shares
373
Price
$34.73
Total Value
$12.95K
Shares Held After
102,363
% of Holdings
0.4%
Jun 30, 2026
Sale
Shares
600
Price
$274.94
Total Value
$164.96K
Shares Held After
5,909,870
% of Holdings
0.0%
Jun 30, 2026
Sale
Shares
2,600
Price
$273.91
Total Value
$712.16K
Shares Held After
5,910,470
% of Holdings
0.0%
Jun 30, 2026
Sale
Shares
5,948
Price
$272.98
Total Value
$1.62M
Shares Held After
5,913,070
% of Holdings
0.1%
Jun 30, 2026
Sale
Shares
4,815
Price
$271.91
Total Value
$1.31M
Shares Held After
5,919,018
% of Holdings
0.1%
Jun 30, 2026
Sale
Shares
3,524
Price
$270.92
Total Value
$954.71K
Shares Held After
5,923,833
% of Holdings
0.1%
Jun 30, 2026
Sale
Shares
2,758
Price
$269.90
Total Value
$744.38K
Shares Held After
5,927,357
% of Holdings
0.0%
Jun 30, 2026
Sale
Shares
2,855
Price
$269.03
Total Value
$768.07K
Shares Held After
5,930,115
% of Holdings
0.0%
Jun 30, 2026
Sale
Shares
700
Price
$267.95
Total Value
$187.56K
Shares Held After
5,932,970
% of Holdings
0.0%
Jun 30, 2026
Sale
Shares
100
Price
$266.08
Total Value
$26.61K
Shares Held After
5,933,670
% of Holdings
0.0%
Jun 30, 2026
Sale
Shares
200
Price
$265.07
Total Value
$53.01K
Shares Held After
5,933,770
% of Holdings
0.0%
Jun 30, 2026
Sale
Shares
600
Price
$263.42
Total Value
$158.05K
Shares Held After
5,933,970
% of Holdings
0.0%
Jun 30, 2026
Sale
Shares
600
Price
$261.14
Total Value
$156.68K
Shares Held After
5,934,570
% of Holdings
0.0%
Jun 30, 2026
Sale
Shares
300
Price
$259.87
Total Value
$77.96K
Shares Held After
5,935,170
% of Holdings
0.0%
Jun 30, 2026
Sale
Shares
200
Price
$258.15
Total Value
$51.63K
Shares Held After
5,935,470
% of Holdings
0.0%
Jun 30, 2026
Sale
Shares
500
Price
$257.21
Total Value
$128.61K
Shares Held After
5,935,670
% of Holdings
0.0%
Jun 30, 2026
Sale
Shares
400
Price
$256.17
Total Value
$102.47K
Shares Held After
5,936,170
% of Holdings
0.0%
Jun 30, 2026
Sale
Shares
100
Price
$254.81
Total Value
$25.48K
Shares Held After
5,936,570
% of Holdings
0.0%
Jun 30, 2026
Sale
Shares
300
Price
$253.44
Total Value
$76.03K
Shares Held After
5,936,670
% of Holdings
0.0%
Jun 30, 2026
Sale
Shares
100
Price
$251.93
Total Value
$25.19K
Shares Held After
5,936,970
% of Holdings
0.0%

4D Molecular Therapeutics, Inc. (FDMT)

Bizily Scott — Chief Legal Officer
Jun 30, 2026
Sale
Shares
6,566
Price
$14.00
Total Value
$91.92K
Shares Held After
8,617
% of Holdings
43.2%
Jun 30, 2026
Sale
Shares
100
Price
$249.95
Total Value
$25.00K
Shares Held After
5,937,070
% of Holdings
0.0%
Jun 30, 2026
Sale
Shares
200
Price
$245.12
Total Value
$49.02K
Shares Held After
5,937,170
% of Holdings
0.0%
Jun 30, 2026
Sale
Shares
6,000
Price
$14.80
Total Value
$88.80K
Shares Held After
48,604
% of Holdings
11.0%

Avalo Therapeutics, Inc. (AVTX)

Doyle Mittie — Chief Medical Officer
Jun 30, 2026
Sale
Shares
4,654
Price
$20.00
Total Value
$93.08K
Shares Held After
51,776
% of Holdings
8.2%

Immunome Inc. (IMNM)

Barchas Isaac — Director
Jun 30, 2026
Sale
Shares
101,050
Price
$21.12
Total Value
$2.13M
Shares Held After
308,504
% of Holdings
24.7%
Jun 30, 2026
Sale
Shares
5,179
Price
$10.02
Total Value
$51.89K
Shares Held After
2,075,448
% of Holdings
0.2%
Jun 30, 2026
Sale
Shares
14,800
Price
$9.89
Total Value
$146.40K
Shares Held After
5,735,707
% of Holdings
0.3%

Fermi Inc. (FRMI)

Perry James Richard — Director
Jun 30, 2026
Sale
Shares
863,637
Price
$7.31
Total Value
$6.31M
Shares Held After
15,827,807
% of Holdings
5.2%

Shattuck Labs, Inc. (STTK)

Shukla Abhinav A. — Chief Technical Officer
Jun 30, 2026
Sale
Shares
23,365
Price
$7.08
Total Value
$165.42K
Shares Held After
86,380
% of Holdings
21.3%

Omada Health, Inc. (OMDA)

Gracey Craig — Chief Accounting Officer
Jun 30, 2026
Sale
Shares
405
Price
$22.00
Total Value
$8.91K
Shares Held After
15,441
% of Holdings
2.6%

Atlanticus Holdings Corp (ATLC)

McCamey William — Chief Financial Officer
Jun 30, 2026
Sale
Shares
10,000
Price
$103.01
Total Value
$1.03M
Shares Held After
127,410
% of Holdings
7.3%

Omada Health, Inc. (OMDA)

Cook Steven L. — Chief Financial Officer
Jun 30, 2026
Sale
Shares
300
Price
$22.00
Total Value
$6.60K
Shares Held After
115,409
% of Holdings
0.3%

Royalty Pharma plc (RPRX)

Hite Christopher — EVP & Chairman, Partnering
Jun 30, 2026
Sale
Shares
600
Price
$57.09
Total Value
$34.25K
Shares Held After
40,000
% of Holdings
1.5%

Royalty Pharma plc (RPRX)

Hite Christopher — EVP & Chairman, Partnering
Jun 30, 2026
Sale
Shares
29,400
Price
$56.44
Total Value
$1.66M
Shares Held After
40,600
% of Holdings
42.0%

Royalty Pharma plc (RPRX)

Hite Christopher — EVP & Chairman, Partnering
Jun 30, 2026
Sale
Shares
2,554
Price
$57.10
Total Value
$145.84K
Shares Held After
459,399
% of Holdings
0.6%

Royalty Pharma plc (RPRX)

Hite Christopher — EVP & Chairman, Partnering
Jun 30, 2026
Sale
Shares
97,446
Price
$56.50
Total Value
$5.51M
Shares Held After
461,953
% of Holdings
17.4%

Shattuck Labs, Inc. (STTK)

Pandite Arundathy N. — Chief Medical Officer
Jun 30, 2026
Sale
Shares
30,000
Price
$7.01
Total Value
$210.30K
Shares Held After
136,219
% of Holdings
18.0%
Version: v26.5.2